FreeIn Brief Kyn Therapeutics partners with Celgene to develop immuno-oncology therapies January 25, 2019Vol.45 No.04
Conversation with The Cancer LetterFree Brawley aims to create a “huge collaboration” in research on disparities January 25, 2019Vol.45 No.04By Paul Goldberg
Free FDA approves 19 new cancer drugs and biologics in 2018—and don’t forget two new endpoints and “real-time” review January 25, 2019Vol.45 No.04By Claire Dietz and Matthew Bin Han Ong
Conversation with The Cancer LetterFree Why austerity measures amid Congressional generosity? Sharpless explains the counterintuitiveSharpless explains the counterintuitive January 25, 2019Vol.45 No.04By Paul Goldberg
FreeObituary John Mendelsohn knew the science. He knew the medicine. He enlisted people to invest in curing and treating cancer January 11, 2019Vol.45 No.02By Raymond N. DuBois
FreeObituary John Mendelsohn understood the urgency of moving discoveries out of the laboratory and into patients January 11, 2019Vol.45 No.02By Margaret L. Kripke
Free John Mendelsohn, translational researcher who led MD Anderson for 15 years, dies at 82 January 11, 2019Vol.45 No.02By Paul Goldberg
FreeObituary A general in BATTLE, Waun Ki Hong was a pioneer of precision medicine January 04, 2019Vol.45 No.01By Roy S. Herbst
FreeObituary Waun Ki Hong, eminent role model, was always years ahead of the field January 04, 2019Vol.45 No.01By Patrick Hwu
FreeObituary Waun Ki Hong, Mentor Magnificus(Aug. 14, 1942 – Jan. 2, 2019) January 04, 2019Vol.45 No.01By Fadlo R. Khuri
